Could polymorphisms of N-acetyltransferase 2 (NAT2), glutathione S-transferase M1 (GSTM1), and cytochrome P450 (CYP1A1) be responsible for genetic predisposition to endometriosis among Japanese?

Journal of Tokyo Medical University

Volumn 61, Issue 1, 2003, Pages 59-66

  Iizuka, Seiko ^a   Kosugi, Yoshinori ^a   Isaka, Keiichi ^a   Takayama, Masaomi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

CYP1A1; Endometriosis; GSTM1; NAT2; Polymorphism

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1; GENOMIC DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; ENZYME POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0037570731     PISSN: 00408905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Simpson JL, Elias S, Malinak LR, Buttram VC Jr: Heritable aspects of endometriosis. 1. Genetic studies. Am J Obstet Gynecol 137: 327-331, 1980
2. Perera FP: Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 88: 496-509, 1996
3. Malinak LR, Buttram VC Jr, Elias S, Simpson JL Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. Am J Obstet Gynecol 137: 332-337, 1980
4. Zeyneloglu HB, Arici A, Olive DL: Environmental toxins and endometriosis. Obstet Gynecol Clin North Am 24: 307-329, 1997
5. Johnson KL, Cummings AM, Birnbaum LS: Promotion of endometriosis in mice by polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls. Environ Health Perspect 105: 750-755, 1997
6. Runnebaum G, Runnebaum B: Fertility disorders may result from heavy metal and pesticide contamination which limits effectiveness of hormone therapy. Zentral bl Gynakol 114: 598-602, 1992
7. Daly AK, Cholerton S, Armstrong M, Idle JR: Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Emvion Health Perspect 102 Supple 9p: 55-61, 1994
8. Nebert DW, McKinnon RA, Puga A: Human drug-metabolizing enzyme polymorphisms: effect on risk of toxicity and cancer. DNA Cell Biol 15: 273-280, 1996
9. Meyer UA, Zanger UM: Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 37: 269-296, 1997
10. Kawajiri K, Fujii-Kuriyama Y: P450 and human cancer. Jpn J Cancer Res 82: 1325- 1335, 1991
11. Guengerich FP, Shimada T: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4: 391-407, 1991
12. Bulun SE, Zeitoun KM, Kikic G: Expression of dioxin-related trasactivating factors and target genes in human eutopic endometrial and endometriootic tissues. Am J Obstet Gynecol 182: 767-775, 2000
13. Bishoff FZ, Marquez-Do D, Kosigi Y, Mitchell-Leef D, Malinak LR, Simpson JL, Elis S: Association of N-Acetyltransferase 2 (NAT2) Genetic Polymorphism Resulting in Decrease Capacity of Detoxify Aromatic Amins in Women with Endometriosis. J Soc Gynecol Invest 5 Jan./Feb., 1998
14. Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R, Baranov V, Malet P, Bruhat MA: Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reproduction 5: 636-641, 1999
15. Grant DM, Tang BK, Kalow W: A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol 17: 459-464, 1984
16. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP: Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 98: 69-74, 1992
17. Blum M, Demierre A, Grant DM, Heim M, Meyer UA: Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 88: 5237-5241, 1991
18. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, Kadluber FF, Lucier GW: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African Americans. Carcinogenesis 14: 1689-1692, 1993
19. Brockoller J, Cascorbi I, Kerb R, Roots I: Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione Stransferase M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915-3925, 1996
20. Hunter DJ, Hankinson SE, Hough H, Gertig DM, Garcia-Closas M, Spiegelman D, Manson JE, Colditz GA, Willett WC, Speizer FE, Kelsey K: A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 18: 2127-2132, 1997
21. Gil JP, Lechner MC: Increased frequency of wild-type arylamine-N acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer. Carcinogenesis 19: 37-41, 1998
22. Baranov VS, Ivaschenko T, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, Malet P, Perriot J, Mouraire P, Baskakov VN, Savitskyi GA, Gorbushin S, Deyneka SI, Michnin E, Barchuck A, Vakharlovsky V, Pavlov G, Shilko VI, Guembitzkaya T, Kovaleva L: Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 97: 516-520, 1996
23. Seidegard J, Vorachek WR, Pero RW, Pearson WR: Hereditary differeces in the expression of the human glutathion S-transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85: 7293-7297, 1988
24. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, Wild N, Leopard P, Bell DA, Jones P, Duncan H, Brannigan K, Alldersea J, Fryer AA, Strange RC: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interaction with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogeneses 17: 881-884, 1996
25. Ketterer B, Taylor J, Meyer D, Pemble S, Coles B, Chulin X, Spencer S: Some functions of glutathione transferases. In: Tew K, Mannervik B, Mantle TJ, Pickett CB, Hayes JD, Eds: Structure and function of glutathione transferaes. Boca Raton, Florida; CRC Press: 15-27, 1993
26. Nakachi K, Imai K, Hayashi S, Kawajiri K: Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-2999, 1993
27. Paraskevaidis A, Drakoulis N, Roots J, Orfanos CE, Zouboulis CC: Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatology 196: 171-175, 1998
28. Sato M, Sato T, Izumo T, Amagasa T: Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 20: 1927-1931, 1999
29. Koizumi A, Nomiyama T, Tsukada M, Wada Y, Omae K, Tanaka S, Miyauchi H, Imamiya S, Sakurai H: Evidence on N-acetyltransferase alleleassociated metabolism of hydrazine in Japanese wokers. J Occup Environ Med 40: 217-222, 1998
30. Harada S, Misawa S, Nakamura T, Tanaka N, Ueno E, Nozoe M: Detection of GSTT1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese. Hum Genet 90: 62-64, 1992
31. Drakoulis N, Cascorbi I, Brockmoller J, Gross CR, Roots I: Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin Investig 72: 240-248, 1994
32. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S: The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14: 77-87, 1993
33. Camus AM, Geneste O, Honkakoski P, Bereziat JC, Henderson CJ, Wolf CR, Bartsch H, Lang MA: High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimetylamine and N-nitrosodiethylamine in mice and humans. Mol Carcinog 7: 268-275, 1993
34. Penman BW, Reece J, Smith T, Yang CS, Gelboin HV, Gonzalez FJ, Crespi CL: Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6. Pharmacogenetics 3: 28-39, 1993
35. Hayes JD, Pulford DJ: The glutathione Stransferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995
36. Zondervan KT, Cardon LR, Kennedy SH: The genetic basis of endometriosis. Curr Opin Obstet Gynecol 13: 309-314, 2001